Clinical Trial Update: Substudy of CADRE: for People With Extreme Phenotype: BIOCADRE

View source ↗

Summary

A clinical trial substudy (BIOCADRE) under the CADRE program is planned for people with extreme phenotype in sickle cell disease; sponsor is Cardiologie et Déve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Cardiologie et Développement | Conditions: Sickle Cell Disease | Status: UNKNOWN